Vascular endothelial growth factor (VEGF) is a promising molecule for cardiovascular
diseases therapy. But lack of a targeted delivery system limits its translation into clinical …

In the UK alone there are 175,000 people who visit Accident & Emergency departments with
burns each year. This results in around 13,000 hospital admissions, of which 1000 are due …

Successful vascularization is essential in wound healing, the histo-integration of
biomaterials, and other aspects of regenerative medicine. We developed a functional in vitro …

In this study, we hypothesize that local sustained release of vascular endothelial growth
factor (VEGF), using adenovirus vector (ADV)-mediated gene transfer, accelerates …

After having demonstrated that the transfer of a well perfused muscle flap predictably
enhances the revascularization of ischemic tissue, further studies revealed the presence of …

It has become evident that a closely regulated presence of vascular endothelial growth
factor (VEGF) and angiopoietin (Ang) factors determines the fate of blood vessel formation …

Background. Injections of single-dose vascular endothelial growth factor (VEGF) 165 have
been advocated as a therapeutic tool for angiogenesis in ischemic flaps. We challenged this …

VEGF is a secreted mitogen associated with angiogenesis and is also a potent vascular
permeability factor. The biological role of VEGF in the ischemic brain remains unknown. This …

Vascular endothelial growth factor (VEGF) is a mitogenic, angiogenic, and potent mediator
of vascular permeability. It plays a role in injuries, contributes to edema during the acute …

L-PRF is an autologous blood-derived biomaterial (ABDB) capable of releasing biologically
active agents to promote healing. Little is known about its release profile of growth factors …